| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6119515 | Journal of Clinical Virology | 2016 | 7 Pages |
Abstract
We found similar sensitivity for CIN3+ in PreservCyt and SurePath for 5 nucleic acid tests in the two media in a referral population, but signal strength and positivity rates were lower in SurePath except for the Onclarity test. These results need to be replicated in a screening population.
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Jack Cuzick, Amar S. Ahmad, Janet Austin, Louise Cadman, Linda Ho, George Terry, Michelle Kleeman, Lesley Ashdown-Barr, Deirdre Lyons, Mark Stoler, Anne Szarewski,